Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvoxamine and Sertraline in Childhood Autism
NCT00655174Phase 3Completed
- Sponsor
- SickKids
- Start
- Jun 1999
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluvoxamine, sertraline in Autism Spectrum Disorder (ASD), sponsored by SickKids. Started Jun 1999; status: completed.
02
Drugs
fluvoxaminesertraline
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00655174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655174.